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BACKGROUND: Recent advances in our basic knowledge of the tissue damage and regeneration pathology have combined with a remarkable 
progress in stem cell biology so the prospect of clinical 
tissue repair strategies is a tangible reality. We tried to 
describe a better view about mesenchymal stem cell (MSC) 
mechanisms in wound healing and tissue regeneration, 
sending any ideas for next advanced therapies.
CONTENT: Sustaining injury, whether minor or major, is 
part of every organism life. Therefore, efficient response 
mechanisms to damage have developed. Wound healing is 
a perplexing multi-step processes which can be divided into 
three major phases: inflammation, proliferation, and scar 
formation/remodeling. Though the compartementalization 
of this process into discrete stages give the illusion of 
simplicity, but in reality it is much more complicated. So that 
efficient healing can occur, complex interactions between 
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multiple cell types, soluble factors and extracellular matrix 
components are required to rebuild the tissue. Even under 
optimal conditions, the healing process drives to fibrosis or 
scar. The latest technology that makes a huge difference in 
the wound healing process is stem cell therapy, which offers 
a novel approach to many diseases. 
SUMMARY: Wound healing therapies continue to rapidly 
evolve, with advances in basic science and engineering 
research heralding the development of new therapies, as 
well as ways to modify existing treatments. Stem cell-based 
therapy is one of the most promising therapeutic concepts 
for wound healing. Advances in stem cell biology have 
enabled researchers and clinicians alike with access to cells 
capable of actively modulating the healing response.
KEYWORDS: wound healing, tissue regeneration, stem 
cells therapy
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Introduction
For centuries, biologists have marveled at the ability of 
organisms such as salamanders to regrow near perfect copies 
of amputated body parts through a precisely orchestrated 
process called epimorphic regeneration. Epimorphic 
regeneration occurs via the formation of a blastema, a mass 
of undifferentiated and differentiated cells containing a 
heterogeneous pool of progenitor cells. The few mammalian 
tissues which are capable of regenerating, such as blood, 
skeletal muscle and epithelium, renew predominantly 
through stem cells, instead of forming a blastema. However, 
stem cell-based regeneration has not proven widely effective 
for most tissues plagued by degenerative processes such 
as the heart and nervous system.(1) We tried to describe 
a better understanding about the role of mesenchymal 
stem cell (MSC) in wound healing and tissue regeneration 
mechanisms in this review, perhaps to send any ideas for 
a more comprehensive and effective therapy in wound 
healing.
 Regenerative medicine is defined as the process 
of creating living, functional tissues to repair or replace 
tissue or organ function lost due to age, disease, damage 
or congenital defects.  Because  of their  extensive  ability 
to  self-renew  and  to  generate  differentiated  progeny, 
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stem  cells  are   the   focus   of    many  applications   in 
regenerative   medicine.(2,3,4)  Regenerative medicine  is 
an  emerging  field  with the potential to reduce the need 
for organ transplantation. It refers to the mechanisms where 
adult organisms restore form and function to damaged 
tissues and organs, focusing on three main aspects, 
each of which has drawbacks. First, the elucidation of 
mechanistic aspects of embryonic development is crucial 
to understanding regeneration, however, the field is far 
from yielding therapeutically applicable outcomes from 
this knowledge. Second, studying adult tissue turnover and 
replacement in an evolutionary context, using efficiently 
regenerating vertebrate species such as fish or salamanders 
to analyze mechanisms of repair often seems distant from 
a mammalian perspective and relatively slow to yield 
mechanistic information. Third, the identification and use of 
adult and pluripotent stem cells in regenerative medicine has 
attracted huge scientific and public interest, but until now 
their clinical application to tissue repair has had minimal 
impact. Human clinical stem cell therapy studies are being 
performed and have often utilized autologous stem cells but 
have not typically focused on  modification  of  the  target 
tissue  to  optimize  their effect.(5)
 Wounds, both chronic and acute, continue to 
be a tremendous socioeconomic burden. As such, 
technologies drawn from many disciplines within science 
and engineering are constantly being incorporated into 
innovative wound healing therapies.(6) Healing a wound 
is, no matter how simple the organization of a cellular 
system, always the result of sequential steps, where each 
one taking the damaged area one step closer to restoring 
cellular architecture and function.(7,8,9) If tissue integrity 
and homeostasis are about to be restored in the moments 
after an injury occurs, various intracellular and intercellular 
pathways must be activated and coordinated. Cellular 
components of the immune system, the blood coagulation 
cascade and the inflammatory pathways are activated 
in addition. Many types of cell, including immune cells 
(neutrophils, monocytes, lymphocytes and dendritic cells), 
endothelial cells, keratinocytes and fibroblasts, undergo 
marked changes in gene expression and phenotype, leading 
to cell proliferation, differentiation and migration.(10,11) 
If this response is successful and the injury does not result 
in the downfall of the organism, these processes must be 
shut down in a precise sequence in the following days 
as recovery progresses.(12,13) For most injuries, repair 
results in once functional tissue becoming a patch of cell, 
mainly fibroblasts, and disorganized extracellular matrix 
(ECM), mainly collagen, which is usually referred to as 
The Cell Biology of Regeneration 
a scar. Surprisingly, in some eukaryotic organisms, the 
response to injury can perfectly recapitulate the original 
tissue architecture, through the incompletely understood 
process of regeneration. Humans have this ability during 
the prenatal development, but it is lost during adult life.(14) 
How regeneration occurs and why humans lose this ability 
remain a mystery.(15)
 Problems with wound healing mostly manifest in 
human can be either delayed wound healing (happens a 
lot in diabetic patients or radiation exposure), or excessive 
healing resulted in hypertrophic and keloid scars, due 
to large amounts of ECM deposit and alteration in local 
vascularization folowed with cell proliferation. This 
excessive reactions often known as “bad scar”.(16) The goal 
of such research is an ancient one, described in the Greek 
myth of Prometheus, that is to change wound healing from 
a process of imperfect repair to complete regeneration.(6)
Regeneration of complex structures after injury requires 
dramatic changes in cellular behavior. Regenerating tissues 
initiate a program that includes diverse processes such as 
wound healing, cell death, dedifferentiation, and stem (or 
progenitor) cell proliferation. Moreover, newly regenerated 
tissues must integrate polarity and positional identity cues 
with preexisting body structures.(17) Gene knockdown 
approaches and transgenesis-based lineage and functional 
analyses have been instrumental in deciphering various 
aspects of regenerative processes in diverse animal models 
for studying regeneration.(9,17)
 After  amputation,  local  responses  at  the  site  of  the 
wound play important roles in the initiation of regenerative 
processes. Wound healing, ion flux, and interactions 
between  the  wound  epidermis   and  the   underlying 
tissue  appear  urgently important  for regenerative 
outgrowth.(16,18) Recent work offers that programmed cell 
death may play a role in triggering regenerative responses 
in many different organisms.(19) Apoptotic cells have been 
observed during early phases of regeneration in several 
animals that can regenerate missing tissues, for examples 
planarians, xenopus, and newts.(20-24) Apoptotic cells have 
been shown to provide a number of signals that can regulate 
wound healing and regeneration. Mitogen-activated protein 
(MAP) kinases signaling through Jun kinase is important 
both for initiating apoptosis and production of wingless/
integrated (Wnt) and bone morphogenic protein (BMP) 
mitogens.(25-27) The further to which these factors are 
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required for stimulating compensatory proliferation remains 
unclear.
 Injury-induced apoptotic signals are also necessary 
to maintain tissue homeostasis. When cells of the adult 
Drosophila midgut are injured by toxins or induced to 
undergo apoptosis, intestinal enterocytes secrete the 
cytokine. Unpaired, which prompts proliferation of 
intestinal stem cells through activation of the Jak/Stat 
pathway.(28) Similarly, in the mouse intestine massive 
induction of apoptosis via intestine-specific knockout of the 
p53 inhibitor mouse double minute 2 homolog (Mdm2), it is 
eventually compensated in adults by increased proliferation 
and expansion of the stem cell pool.(29) Apoptotic cells 
also contribute to homeostasis in epithelia by lipid-based 
signaling, for example sphingosine-1-phosphate, which 
triggers actomyosin contraction in the surrounding cells, 
leading to the extrusion of the dying cells.(30) These 
observations suggest many potential roles for dead and 
dying cells to alter cell behavior at sites of injury.
 New cells can be generated in a sort of ways, including 
proliferation of a resident stem cell population, division 
of terminally differentiated cells, or dedifferentiation/
transdifferentiation of mature cells to a stem cell-like 
precursor or another cell type. The extent to which each 
mode is used differs between species and even across tissues 
within the same species.(17) The source of regenerative 
cells in vertebrates varies between tissues and organisms, 
and in some cases stays as a matter of continued debate. 
Mature stem cells contained in many vertebrate tissues 
play important role in tissue regeneration, turnover and 
homeostasis in several contexts through the process of 
division, dedifferentiation, and transdifferentiation. In 
extreme damage or chronic liver disease, liver progenitor 
cells appear to be the major sources for new hepatocytes 
regeneration, while in partial hepatectomy or mild liver 
injury the liver mass restoration majority accomplished 
through proliferation of remaining hepatocytes.(31) 
Similarly, recent lineage-tracing experiments indicate 
that after damage to the zebrafish heart, the existing 
cardiomyocytes undergo dedifferentiation and proliferate to 
generate  new  cardiomyocytes  for  replacing  lost  heart 
mass.(4,32,33)
 Investigations of model organisms have begun to 
characterize the cellular sources of regeneration, define their 
potency, and also identify molecules required for restorative 
events. Therefore, there is a great opportunity for cell 
biological studies to link gene function to cellular behavior 
in the moment. One of the long-term goals of regeneration 
research is to understand why humans have such limited 
regenerative potential and what can be done to improve it, 
if there is any. The knowledge acquired from studying cell 
biological questions in model organisms should supports 
turn such future efforts of regenerative medicine.
The capacity to respond to injury and to repair tissue is a 
fundamental property of all multicellular organisms. But 
there is astounding diversity in how this process occurs. 
Studying wound repair in various phyla could improve our 
understanding of wound repair in humans and might help 
to identify molecules or pathways that can be targeted to 
restore the lost regenerative capacity. In general, the wound 
repair process happens in almost all tissues after exposure 
to almost any destructive stimulus. Thus, the sequence of 
events that follows a myocardial infarction (heart attack), 
for example, is remarkably similar to that following a 
spinal-cord injury, a burn or a gunshot wound, despite the 
different types of insult and the different organs affected. 
Likewise, scar formation which occurred during wound 
repair leads to similar tissue dysfunction wherever it takes 
place. In the case of myocardial infarction, the formation 
of myocardial scar tissue is thought to result in congestive 
heart failure, a condition in which the heart cannot supply 
body’s tissues with enough blood, and/or abnormal heart 
rhythms (arrhythmias).(16)
 Wound healing is an essential biological process 
that  consists  of  sequential  steps  aimed  at restoring 
the   architecture   and    function    of    damaged    cells 
and   tissues.(8) Traditionally, mammalian wound healing 
is described as occurring in three overlapping stages: 
inflammation, proliferation and remodeling (Figure 1).(16) 
The process of wound healing technically starts at the 
moment of injury with inflammation. The body’s initial 
response, formation of a fibrin clot, provides hemostasis 
and recruits several types of cells to the wound.(34) The 
first circulating immune cells to arrive are neutrophils, 
with highest concentrations found 1 to 2 days post-injury. 
They function in preventing bacterial infection (given 
the disrupted epithelial barrier) as well as in activation of 
keratinocytes, fibroblasts and immune cells.(34,35) Early 
migration of keratinocytes along the temporary  fibrin  ECM 
is  seen  within  hours  of wounding.(10)
 Circulating monocytes arrive and differentiate into 
macrophages 2-3 days after the  injury. During the early 
inflammatory phase of wound healing, macrophages 
The Process and Molecular Mechanisms of Wound Healing  
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Figure 1.  Cancer Classic stages of wound repair. There are 
three classic stages of wound repair: inflammation (a), new tissue 
formation (b) and remodeling (c).(20) (Adapted with permission 
from Nature Publishing Group).
 Completion of re-epithelialization is also attained 
during the proliferative stage of wound healing. This 
process involves migration, proliferation and differentiation 
of keratinocytes drawn from both wound edges and stem 
cell   populations  found   in   the  hair    follicle    bulge 
region.(38) Despite the participation of stem cells, epidermal 
appendages    are    not    regenerated    during    wound 
healing.(34) Re-epithelialization is aided by the production 
of a replacement ECM by fibroblasts. Components of the 
ECM such as fibronectin, along with cytokines such as 
TGF-β1 and certain inflammatory mediators produced 
during the immune response to injury, induce fibroblast 
activation.(39-41) Activated fibroblasts, or myofibroblasts, 
so named due to the contractile ability provided by their 
expression of alpha smooth muscle actin (α-SMA), respond 
physically and biochemically to the mechanical environment 
of the wound. Physically they contract, adequating to bring 
the edges  of   the   wound  together,   decreasing  its overall 
size.(16,42) They are also responsible for the secretion of 
the abnormal ECM-characterizing scar tissue.(43) This 
ECM primarily varies from that of unwounded skin and 
mature scars in its collagen content, containing increased 
levels of immature type III collagen, which is relative to the 
mature type I collagen that predominates in normal skin and 
mature scar.(6,43)
 Comprehensive understanding in normal and 
pathological wound healing process, either cellular or 
molecular will provide the possibility for more targeted, 
efficient therapy development. Knowing the stem cells 
multipotent and self-renewing properties, along with their 
low immunogenicity, stem cell application give a positive 
opportunity for another emerging paradigm for acute and 
chronic wound treatment. Stem cells from a variety of 
sources have proven to be successful in experimental 
wound healing applications, and are now being tested in 
many preclinical and clinical trials.(44)
Dysfunctional healing results in either a persistent open 
wound, or excessive, disorganized cellular proliferation 
driving to a hypertrophic or keloid scar. Both of these 
extremes of wound healing can lead to significant functional 
impairment, psychosocial morbidity and overall increased 
health-care costs.(6) Fibrosis is an immensely conserved 
and coordinated protective response to tissue injury. The 
interaction of multiple pathways, molecules and systems 
function alongside neutrophils in preventing infection and 
help to debride the wound of necrotic tissue.(16,36) As the 
inflammatory stage of wound healing ends and  proliferation 
begins, macrophages adopt an anti-inflammatory, profibrotic 
phenotype. The growth factors they produce, such as 
transforming growth factor (TGF)-β, recruit fibroblasts from 
the surrounding uninjured tissue.(34,36) These and other 
cells stimulate the migration of endothelial cells into the 
wound via production of vascular endothelial growth factor 
(VEGF), among other factors, resulting in the formation of 
new blood vessels and, thus, the hypervascular character of 
granulation tissue.(37)
Tissue Regeneration in Wound Healing and Fibrosis
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determines whether fibrosis is self-limiting and homeostatic, 
or whether it is uncontrolled and excessive. Immune cells 
have been identified as key players in this fibrotic cascade, 
which have the capacity to exert either injury-inducing 
or repair-promoting effects. A multi-organ approach was 
recently suggested to identify the core and regulatory 
pathways in fibrosis, aiming to integrate the wealth of 
information emerging from basic fibrosis research.(45)
 Dysfunctional inflammation has also been implicated 
in hypertrophic scarring. Specifically, hypertrophic scars 
are related to a prolonged inflammatory phase of wound 
healing. This may be associated with the mechanism of 
injury, as they typically occur after burn injury or other 
trauma to the deep dermis.(46) In contrast, keloid formation 
is determined by both genetic and environmental factors: 
they are predominantly seen in darker skinned individuals 
and the propensity to form them can be inherited.(47,48) 
Clinically, both hypertrophic scars and keloids present as 
pruritic, raised, reddened and firm masses, although a keloid 
will extend beyond the borders of the original wound.(49) 
They may be both cosmetically distressing and, due to 
scar contractures, functionally debilitating.(50,51) While 
a hypertrophic scars will partially regress (undergo a 
remodeling phase), a keloid will not.(48)
 Fibrosis becomes problematic and clinically relevant 
when dysregulated and excessive scarring occurs in 
response to persistent injury and drives to altered tissue 
function. Healing by fibrosis, instead of regeneration, 
places a huge burden on public health. The total economic 
cost of diseases which is resulted from fibrosis is difficult 
to calculate precisely, but  it  is  of  the  order  of  tens  of 
billions  of dollars.(52) Importantly, dysfunctional healing 
often causes lifelong   disability,  which  has  a  significant 
economic  impact.(11) Thus, if fibrotic healing processes can 
be transformed into regenerative ones, in which the original 
tissues are restored, this would considerably improve 
human health.(16) Stem cell-based therapy is one of the 
most promising therapeutic concepts for wound healing. 
Advances in stem cell biology have enabled researchers 
and clinicians alike with access to cells capable of  actively 
modulating  the  healing  response.(6)
Macrophages found in all tissues, play a role in tissue 
development, homeostasis, repair and immunity, known 
as the most plastic cells in the haematopoeietic system as 
they show great functional diversity. They are anatomically 
different from one to another, and have a different 
transcriptional profiles and functional capabilities, but 
they are all required for tissue homeostasis maintenance. 
However, subverted of nay of these reparative and 
homeostatic functions due to chronic insults, can result in 
a macrophages associated disease states.(53) Macrophages 
likely represent the pre-eminent cells in the body endowed 
with the ability to migrate within tissues, even in hypoxic 
conditions, and with the capacity to modify the ECM and 
amplify paracrine signals.
 Wound healing is a complex biological process 
that occurs frequently during adulthood and requires the 
interplay among different cell types, including keratinocytes, 
fibroblasts and immune cells.(54) Early studies suggested 
that macrophages and neutrophils play a crucial role 
during skin wound healing. Macrophages are generally 
believed to orchestrate the repair process by acting both as 
phagocytes, to clear cellular debris, and as a major source 
of growth factors (e.g., proangiogenic factors, epithelial-
cell growth factors, etc.).(55) Depletion of macrophages 
during the subsequent phase of the repair response (tissue 
formation) caused severe hemorrhage in the wound tissue 
and prevented tissue maturation and wound closure. 
Macrophage depletion during the late stage of repair (tissue 
maturation) did not significantly impact the outcome of the 
repair response. These interesting observations suggest that 
macrophages exert distinct functions during the diverse 
phases of skin repair. In particular, macrophages appear 
to play an important role in promoting angiogenesis in the 
granulation tissue during the early phase of skin repair, and 
in vascular maturation and stabilization in the subsequent 
phases.(56) Distinct types of wound healing macrophages 
have been described to date. Their phenotypic and functional 
characterization is, however, not yet exhaustive.(54)
 Recruitment  of  macrophages to the wound healing 
site  may  rely on  different signals, such as chemokine 
C-C motif ligand 2 (CCL2)/monocyte chemotactic protein 
1 (MCP1), macrophage inflammatory protein-1alpha 
(MIP1a), but  also  stromal  cell-derived  factor 1 (SDF1)/
C-X-C motif chemokine 12 (CXCL12) and  granulocyte-
colony  stimulating  factor  (G-CSF).(57)  Okuno  and  co-
workers  showed  that colony  stimulating factor (CSF)-1 
is  early  up-regulated  at  the  wound  healing  site and 
play an important   role in recruiting  macrophages.(58) 
Thus,  wound   healing  macrophages  may  exert  their 
proangiogenic   programs   by    physically  interacting 
with  sprouting   blood  vessels,    facilitating    their growth 
by  degrading  the ECM,  and/or   promoting   vascular 
The Role of Macrophages in Wound Healing and Tissue Regeneration
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remodeling    via   non-canonical  (e.g., VEGF-independent) 
angiogenic pathways.(59)
 Sindrilaru and co-workers recently reported that 
human chronic venous ulcers contain increased proportions 
of macrophages markers (e.g., nitric oxide synthase 
(NOS)2 and tumor necrosis factor (TNF)-a than healing 
wounds.(60) Successful mammalian regeneration requires 
precise coordination of multiple processes, which include 
scavenging cellular debris, proliferation and activation of 
progenitor cells, immune modulation, angiogenesis and 
innervation of the newly forming tissue.(1) 
 Following conditioning by the inflammatory milieu 
including local growth factors and cytokines, macrophages 
polarize into classically activated (M1) or alternatively 
activated (M2) subtypes based on their markers, function, 
and cytokine profiles.(55) Typically, M1 cells produce high 
levels of pro-inflammatory cytokines and NOS which aid 
in host defense but can also damage healthy tissue while 
M2 macrophages mediate wound healing, tissue repair and 
the resolution of inflammation. Nevertheless, M1 cells can 
also have a positive role in tissue regeneration. In the heart 
and skeletal muscle, early infiltration by M1 macrophages 
facilitates clearance of necrotic tissue (61,62), and disrupting 
macrophage polarization impairs healing and regeneration, 
respectively (63).
 Perhaps the strongest link between immune-mediated 
debris clearance and regenerative capacity has been 
documented in the central nervous system (CNS) and 
demyelinating diseases (Figure 2). The sensitivity of the 
CNS to debris clearance may be attributed to the plentiful 
inhibitory properties of myelin, the membrane sheath that 
insulates axons, when deposited in damaged tissue. While 
remyelination is robust in the CNS of young, healthy mice, 
the ability to restore the myelin sheath declines with age 
or in disease.  Clearance of myelin debris depends on 
macrophages  and  recent  data  suggest  that  the  decline 
in efficient  CNS  regeneration  is linked  to  the immune 
system.(64) 
 Study by Heredia, et al., showed that skeletal muscle 
regeneration was mediated by interleukin (IL)-4-secreting 
eosinophils which activating fibro/adipocyte progenitors 
(FAP) for necessary debris clearance to enhance the 
effective regeneration. In the absence of IL-4, FAPs do not 
clear debris, but instead differentiate into adipocytes, which 
contribute to muscle degeneration (Figure 2).(1)
 In kidney regeneration, macrophage-derived Wnt7b 
is needed for renal tubular epithelial regeneration.(65) 
Cross-talk between the immune system and progenitor cell 
populations mediated by critical modulators of cell to cell 
signaling such as Notch and Wnt therefore seems to be a 
generally known regenerative signaling pathway in different 
tissues. The immune system also affects progenitor and 
stem cells by creating the appropriate microenvironment for 
their development and function (Figure 3).(1)
 Both arms of the immune response are required for 
repair in many systems, for examples in heart, skeletal 
muscle, and the CNS. If initial, pro-inflammatory signals 
are not controlled, for example, excessive tissue damage 
can occur and block repair. Conversely, premature initiation 
of the anti-inflammatory program can also disrupt efficient 
tissue healing; for example, skeletal muscle regeneration 
is impaired when macrophages are prematurely skewed 
by treatment with IL-10 or genetic loss of MAP kinase 
phosphatase-1 (MKP-1).(63) Also, in both skeletal muscle 
regeneration and remyelination, M1 macrophages recruit and 
stimulate progenitor proliferation while M2 macrophages 
mediate differentiation, dispelling the common view that 
M1 macrophage responses are overall bad while M2 are 
good.(1)
 The re-establishment of adequate blood flow to injured 
and newly forming tissue is a key aspect of regeneration. 
Immune cells help developmental angiogenesis by secreting 
soluble factors, remodeling matrix and physically pruning 
and supporting the vasculature during the maturation 
process. In the developing mouse retina, vessel remodeling 
is under the control of macrophages via expression of 
the Wnt ligands Wnt5a and Wnt11 (66), that enhance the 
Figure 2.  Debris clearance as a coordinator of regeneration. 
Debris clearance orchestrated by the immune system is a key 
activator of subsequent steps in regeneration, including progenitor 
cell activation, differentiation, and immune polarization.(1) 
MØ: macrophage; AMPK: AMP-activated protein kinase, OPC: 
oligodendrocyte precursor cell. (Adapted with permission from 
Elsevier).
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Figure 3.  Immune cell polarization and heterogeneity 
are key components of tissue repair or regeneration. 
The regenerative capacity of skeletal muscle is driven by 
satellite cell activation, proliferation and differentiation.
(1) MØ: macrophage; IGF: insulin-like growth factor. 
(Adapted with permission from Elsevier).
expression of the VEGF inhibitory receptor Fms-Related 
Tyrosine Kinase 1 (FLT1). Interestingly, genetic disruption 
of the myeloid non-canonical Wnt pathway can enhance 
wound angiogenesis and repair, suggesting the same 
signaling pathway found in the retinal vasculature could 
have therapeutic applications for modulating myeloid cell 
signaling to treat wounds.(67) The significance of immune 
regulation of angiogenesis, progenitor cell activity, debris 
removal, and appropriate polarization of subsequent 
immune responses and soluble factor secretion suggests 
that a closer look at pro-regenerative therapeutics targeted 
at immunity is warranted.
MSCs are multipotent cells which have the capacity for 
self-renewal and differentiation and have a wide tissue 
distribution. These characteristics make them candidate 
cells for wound healing and regeneration in different kind 
of disorders. Endogenous and exogenously delivered MSCs 
can traffic and migrate to injured tissue, participating in 
tissue healing process. Even the concentrated conditioned 
medium from MSCs can modulate wound repair without 
MSCs themselves being present in the tissue. This suggest 
that MSC therapeutic effects acquired through their ability to 
differentiate and transdifferentiate into tissue-specific cells, 
to fuse with the native cells, and to stimulate resident cells 
survival and functional recovery by secreting a parade of 
paracrine factors which regulate the local microenvironment 
(niche) and immune response.(68)
 MSCs may be obtained from different areas in the 
body, with the most generally known sources being bone 
marrow (BM-MSC) and adipose tissue (ASC). While 
differences in the phenotype of BM-MSCs and ASCs 
have been observed, both have proven to be efficacious 
in wound healing therapies.(69) MSC that appears to be 
a native constituent of the wound bed (70), have emerged 
as an alternative to the standard pharmaceutical treatment 
modalities. These cells are critical trophic mediators to 
promote tissue regeneration and can be readily derived from 
a variety of autologous or allogeneic adult tissues, also from 
commercial providers.(71) The versatility of these cells has 
made them an attractive candidate for clinical translation in 
many different therapeutic applications. In particular, MSCs 
may offer the means of recapitulating several mechanisms 
which are sufficient for inhibition of scar formation in skin 
wounds.(72)
 If the inflammatory phase is prolonged, the pro-
inflammatory mediators will direct the wound healing cells, 
such as myofibroblasts and fibrocytes, in generating the non-
functional, void-filling tissue that will result in the formation 
of a scar.(73) Scars are a consequence of cutaneous wound 
healing that can be both unsightly and detrimental to the 
function of the tissue. After the MSCs enter the inflammatory 
environment, their immunomodulatory phenotype becomes 
activated by interferon (IFN)-γ, TNF-α and IL-1β.(74) The 
ability of MSCs to regulate T-cell recruitment, proliferation 
and activity is well documented.(74,75) There is also 
evidence that MSCs are able to suppress the proliferation of 
B cells (76) and natural killer cells (77), through ameliorating 
the acute immune response to injury. By attenuating the 
function of these cell types, the MSCs would likely reduce 
the pro-fibrotic responses which can occur coincident with 
the prolonged inflammation during wound healing.(78,79)
 Angiogenesis is an important process during the 
proliferation phase of wound healing to provide the 
fibroblasts with sufficient nutrient supply for the production 
of a provisional granulation matrix.(80) Unsuccessful in 
generating an adequate microvascular can induce wound 
MSC in Wound Repair and Regeneration 
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closure deficiencies, develop into a chronic non-healing 
wound. Another important thing is a stable transitional 
vessels as the tissue remodels and forming a permanent 
vascular network. MSCs produce basic fibroblast growth 
factors (FGF) and VEGF-A, in addition to macrophages 
and fibroblasts, which provide powerful mitogenic cues 
to promote proliferation, migration and differentiation 
of microvascular endothelial cells.(81,82) MSCs also 
express paracrine factors to promote vascular stability and 
vasoprotection (83,84), including adrenomedullin (85). It 
has been hypothesized that these functions are unique to 
MSCs because of their possible perivascular origin, and 
they are able to exploit these functions to recreate their 
perivascular niche as the process of vasculature remodeling 
is concluded.(86)
 More interesting and relevant is recent evidence 
showing that MSCs may transdifferentiate to epidermal 
cells, keratinocytes and microvascular endothelial cells 
under defined conditions in vitro.(87-89) Finally, MSCs may 
also transdifferentiate into keratinocytes under conditions 
that allow them to interact with native epidermal cells.(90) 
These studies suggest that MSCs could participate directly 
in the structural regeneration of dermal and epidermal 
tissues, so representing an additional mechanism by which 
the MSCs may promote cutaneous wound healing. Based 
on a variety of small and large animal studies, a growing 
body of evidence finds that MSCs provide significant 
benefit during dermal wound healing, as they can accelerate 
the rate of wound closure and re-epithelialization, improve 
the quality and strength of the regenerated tissue, recover 
wound healing pathologies that might otherwise result in 
a chronic, non-healing wound, and minimize the visual 
appearance of scar tissue.(72)
Wound healing is a dynamic process involving complicated 
interactions between multiple cell types, molecules 
and the ECM. What limited the development of the 
effective treatments for wound healing is the incomplete 
understanding of the pathophysiology of both normal and 
abnormal wound healing responses. Addition of certain 
growth factors and cytokines to wounds has resulted in 
improved wound healing, both in experimental models and 
clinically. An increasing understanding of stem cell biology 
has guided to the development of cell-based therapies able 
to affect multiple aspects of wound healing. Stem cell 
therapies hold huge promise as we continue to search for 
ways to regenerate damaged tissues. As our knowledge 
continues to improve, emerging technologies will allow 
for the development of safe, specialized wound therapies 
recreating the physical and chemical properties of the stem 
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